by Cara Blake, DVM, DACVS-SA, CCRT; Lisa Mason, DVM, CCRT, CVA, CVPP; Heather Owen, DVM, MAV, CCRP, MT, CCFT; Ashton Thompson, DVM, CCRT, CVMA
-
Discover expert insights on treating osteoarthritis and effective client communication.
This panel discussion focuses on the differences between new systemic therapies such as anti-nerve growth factor drugs and localized approaches to treating musculoskeletal pain.
Experts in orthopedics, rehabilitation therapy, and pain management will discuss how managing a patient with a multimodal approach results in best outcomes and how you can best communicate to pet owners that there is no "magic pill’ when it comes to treating their pet’s pain.
Learning Objectives- -How orthopedic disease and trauma impact the joint and why local pain management approaches must be considered
-The role of nerve growth factor in pain pathways
-Getting a specific diagnosis and how that leads to optimal outcomes when utilizing a multimodal pain management plan
-Communicating with clients about why pain management requires more than just a ‘magic pill’ approach - -How consistent care leads to earlier intervention and better results
-The appropriate use of anti-nerve growth factor therapies in patients with osteoarthritis and their special considerations
- -How orthopedic disease and trauma impact the joint and why local pain management approaches must be considered